Microvision (MVIS) | Financial Analysis & Statements
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
4.7M
Gross Profit
-2.8M
-60.35%
Operating Income
-81.2M
-1,729.02%
Net Income
-96.9M
-2,063.78%
EPS (Diluted)
-$0.46
Balance Sheet Metrics
Total Assets
121.2M
Total Liabilities
72.4M
Shareholders Equity
48.8M
Debt to Equity
1.48
Cash Flow Metrics
Operating Cash Flow
-77.1M
Free Cash Flow
-68.9M
Revenue & Profitability Trend
Microvision Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 4.7M | 7.3M | 664.0K | 2.5M | 3.1M |
| Cost of Goods Sold | 7.5M | 2.8M | 100.0K | 2.0K | 1.4M |
| Gross Profit | -2.8M | 4.5M | 564.0K | 2.5M | 1.7M |
| Operating Expenses | 78.4M | 93.4M | 54.5M | 46.4M | 15.8M |
| Operating Income | -81.2M | -88.9M | -53.9M | -43.9M | -14.1M |
| Pre-tax Income | -96.4M | -81.7M | -53.1M | -43.2M | -13.6M |
| Income Tax | 507.0K | 1.1M | 0 | 0 | - |
| Net Income | -96.9M | -82.8M | -53.1M | -43.2M | -13.6M |
| EPS (Diluted) | -$0.46 | -$0.45 | -$0.32 | -$0.27 | -$0.10 |
Income Statement Trend
Microvision Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 82.5M | 86.8M | 91.0M | 119.4M | 17.6M |
| Non-Current Assets | 38.7M | 42.9M | 24.0M | 10.8M | 3.4M |
| Total Assets | 121.2M | 129.6M | 115.0M | 130.2M | 21.0M |
| Liabilities | |||||
| Current Liabilities | 46.0M | 20.5M | 11.4M | 12.5M | 10.0M |
| Non-Current Liabilities | 26.4M | 13.3M | 13.8M | 5.0M | 2.0M |
| Total Liabilities | 72.4M | 33.8M | 25.3M | 17.5M | 12.0M |
| Equity | |||||
| Total Shareholders Equity | 48.8M | 95.8M | 89.7M | 112.8M | 9.0M |
Balance Sheet Composition
Microvision Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -96.9M | -82.8M | -53.1M | -43.2M | -13.6M |
| Operating Cash Flow | -77.1M | -72.4M | -39.1M | -30.4M | -14.2M |
| Investing Activities | |||||
| Capital Expenditures | -374.0K | -1.9M | -4.4M | -2.5M | 123.0K |
| Investing Cash Flow | 2.7M | 21.8M | -38.1M | -35.3M | 123.0K |
| Financing Activities | |||||
| Dividends Paid | - | - | - | - | - |
| Financing Cash Flow | 72.8M | 72.3M | 13.6M | 128.5M | 26.0M |
| Free Cash Flow | -68.9M | -69.0M | -42.4M | -31.9M | -16.5M |
Cash Flow Trend
Microvision Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
-2.89
Forward P/E
-3.29
Price to Book
6.22
Price to Sales
77.73
PEG Ratio
-3.29
Profitability Ratios
Profit Margin
-60.35%
Operating Margin
-2,383.70%
Return on Equity
-135.21%
Return on Assets
-33.74%
Financial Health
Current Ratio
1.89
Debt to Equity
91.26
Beta
1.57
Per Share Data
EPS (TTM)
-$0.45
Book Value per Share
$0.22
Revenue per Share
$0.02
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| mvis | 336.5M | -2.89 | 6.22 | -135.21% | -60.35% | 91.26 |
| Garmin | 41.6B | 28.41 | 5.09 | 19.04% | 22.76% | 2.18 |
| Keysight | 28.2B | 38.42 | 5.13 | 14.30% | 14.53% | 50.48 |
| Faro Technologies | 848.8M | - | 3.25 | -0.34% | -0.26% | 35.44 |
| Ituran Location and | 782.8M | 14.21 | 4.11 | 30.71% | 16.35% | 2.74 |
| Mesa Laboratories | 471.5M | 546.59 | 2.95 | -1.29% | -0.82% | 121.29 |
Financial data is updated regularly. All figures are in the company's reporting currency.